Rationale and Design of the Clarification of Optimal Anticoagulation Through Genetics Trial

American Heart Journal - United States
doi 10.1016/j.ahj.2013.04.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Genetics Informatics Trial (GIFT) of Warfarin to Prevent Deep Vein Thrombosis (DVT): Rationale and Study Design

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2011English

Design of the Optimal Trial of Combination Therapy

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2020English

PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Design and Rationale of the High-Sensitivity Troponin T Rules Out Acute Cardiac Insufficiency Trial

Pragmatic and Observational Research
2017English

Rationale and Design of the ADVOR (Acetazolamide in Decompensated Heart Failure With Volume Overload) Trial

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Rationale, Design and Conduct of a School-Based Anti–smoking Intervention: The “PEPITES” Cluster Randomized Trial

BMC Public Health
EnvironmentalPublic HealthOccupational Health
2018English

Resistance Training Volume, Energy Balance and Weight Management: Rationale and Design of a 9month Trial

Contemporary Clinical Trials
MedicinePharmacology
2012English

The STAMPEDE Trial: Paradigm-Changing Data Through Innovative Trial Design

Translational Cancer Research
Cancer ResearchOncologyRadiologyNuclear MedicineImaging
2016English

Self Management of Oral Anticoagulation: Randomised Trial

BMJ
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy